Skip to main content icon/video/no-internet

HUNTINGTON'S DISEASE IS a hereditary type of chorea, which is a neurological condition that is associated with involuntary and irregular movements caused by movements of various muscle groups. It is a fatal disease and had no known cure before the development of certain stem cell treatments. The disease is named after the American doctor George Huntington, who first described the condition in detail in 1872. In fact, most variables of the disease—type and severity of symptoms, age at which onset occurs, effect on lifestyle—can vary considerably. However, it is most commonly observed as becoming manifest in patients between the ages of 30 and 50 years.

It was discovered in 1993 that Huntington's disease is caused by a single gene. A person with one parent who has the gene has a 50 percent chance of inheriting the faulty gene, and if that happens, it is certain that the disease will manifest itself during the lifetime of the patient, except in the case of an early death. Early possible symptoms include short—term memory lapse, behavior change, uncontrolled movement (mild), and clumsiness. As the disease develops, more severe involuntary movement takes place, as well as the loss of communication skills and other effects caused by these symptoms.

These symptoms, especially as they become more severe, can be very distressing, both for the patient and for carers and loved ones. The patient is likely to suffer additional psychological issues including depression and mood swings, which make care provision more trying. A range of medical assistance is likely to be required to deal with the secondary effects of the disease (e.g., psychological counselors, nutritionists, and occupational therapists) in addition to dealing with the root cause. In cases in which the presence of the gene in a family is not known, then it can take some time before the reason for the symptoms becomes clear. Where the presence of the gene is known in the family, then there is an effective test to determine whether it is present in an individual. Embryos are tested for the presence of the gene in some countries before use in in vitro fertilization treatments.

Stem Cell Technologies

Scientists in the United States, United Kingdom, and South Korea, among other countries, are actively involved in using stem cell technologies to try to develop an effective treatment for Hunting—ton's disease. In the United States, for example, the private company StemCells Inc. has entered into a joint venture with the High Q Foundation with a view to developing more accurate models of the disease and, hence, develop a means of combating it. In the United Kingdom, ReNeu—ron Group PLC signed a similar agreement with Angel Biotechnology Holdings PLC to produce a master cell bank that can then be used to tackle the disease.

The high level of technical skills required in this industry, together with the need for highly equipped laboratories and specialized equipment, means that individual companies or university departments are highly unlikely to be able to deploy all the needed resources individually. As a consequence, joint ventures and contract agreements are required to enable organizations to bring together the necessary combination of resources required to approach particular projects. It also, of course, helps to explain the high cost of potential treatments because commercial companies need to recover the expenses they incur in mobilizing all of those resources, and inevitably, all organizations have a need to show a profit for their work. Given how many research projects fail to produce viable, marketable treatments of one sort or another, this means that the ones that do need to show a profit also need to cover the costs of failed projects. This has the unfortunate effect of making treatments effectively beyond the reach of all but the richest societies.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading